Atossa Genetics Earnings Calls

Q1 2025 (Today)
Release date May 12, 2025
EPS estimate -$0.0600
EPS actual -
Revenue estimate -
Revenue actual -
Expected change +/- 9.80%
Q4 2024 Beat
-$0.0500 (16.67%)
Release date Mar 25, 2025
EPS estimate -$0.0600
EPS actual -$0.0500
EPS Surprise 16.67%
Revenue estimate -
Revenue actual -
Q3 2024 Beat
-$0.0500 (16.67%)
Release date Nov 12, 2024
EPS estimate -$0.0600
EPS actual -$0.0500
EPS Surprise 16.67%
Revenue estimate -
Revenue actual -
Q2 2024
Release date Aug 12, 2024
EPS estimate -$0.0500
EPS actual -$0.0500
Revenue estimate -
Revenue actual -

Last 4 Quarters for Atossa Genetics

Below you can see how ATOS performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Q2 2024
Release date Aug 12, 2024
Fiscal end date Jun 30, 2024
Price on release $1.24
EPS estimate -$0.0500
EPS actual -$0.0500
Date Price
Aug 06, 2024 $1.21
Aug 07, 2024 $1.16
Aug 08, 2024 $1.20
Aug 09, 2024 $1.17
Aug 12, 2024 $1.24
Aug 13, 2024 $1.30
Aug 14, 2024 $1.24
Aug 15, 2024 $1.28
Aug 16, 2024 $1.28
4 days before 2.48%
4 days after 3.23%
On release day 4.84%
Change in period 5.79%
Q3 2024 Beat
Release date Nov 12, 2024
Fiscal end date Sep 30, 2024
Price on release $1.50
EPS estimate -$0.0600
EPS actual -$0.0500
EPS surprise 16.67%
Date Price
Nov 06, 2024 $1.48
Nov 07, 2024 $1.50
Nov 08, 2024 $1.50
Nov 11, 2024 $1.62
Nov 12, 2024 $1.50
Nov 13, 2024 $1.37
Nov 14, 2024 $1.37
Nov 15, 2024 $1.28
Nov 18, 2024 $1.28
4 days before 1.35%
4 days after -14.67%
On release day -8.67%
Change in period -13.51%
Q4 2024 Beat
Release date Mar 25, 2025
Fiscal end date Dec 31, 2024
Price on release $0.724
EPS estimate -$0.0600
EPS actual -$0.0500
EPS surprise 16.67%
Date Price
Mar 19, 2025 $0.743
Mar 20, 2025 $0.716
Mar 21, 2025 $0.754
Mar 24, 2025 $0.749
Mar 25, 2025 $0.724
Mar 26, 2025 $0.696
Mar 27, 2025 $0.699
Mar 28, 2025 $0.696
Mar 31, 2025 $0.673
4 days before -2.62%
4 days after -7.03%
On release day -3.80%
Change in period -9.47%
Q1 2025 (Today)
Release date May 12, 2025
Fiscal end date Mar 30, 2025
Price on release -
EPS estimate -$0.0600
EPS actual -
Date Price
May 05, 2025 $0.88
May 06, 2025 $0.83
May 07, 2025 $0.81
May 08, 2025 $0.81
May 09, 2025 $0.82

Atossa Genetics Earnings History

Earnings Calendar

FAQ

When is the earnings report for ATOS?
Atossa Genetics (ATOS) has scheduled its earnings report for May 12, 2025 before the markets open.

What is the ATOS price-to-earnings (P/E) ratio?
ATOS P/E ratio as of May 09, 2025 (TTM) is -4.03.

What is the ATOS EPS forecast?
The forecasted EPS (Earnings Per Share) for Atossa Genetics (ATOS) for the first fiscal quarter 2025 is -$0.0600.

What are Atossa Genetics's retained earnings?
On its balance sheet, Atossa Genetics reported retained earnings of $0 for the latest quarter ending Mar 30, 2025.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT ATOSSA GENETICS INC.
Atossa Genetics
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien...
GOLDEN STAR
Ticker Change Signal Date
BAX
$30.72
0.586% May 07
HBM
$7.41
4.05% May 05
P
PENG
$17.23
2.21% May 05
A
AORT
$23.77
21.62% May 05
PODD
$257.01
20.88% May 02

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE